Skip to main content
. 2016 Oct 13;11(10):e0164648. doi: 10.1371/journal.pone.0164648

Table 3. Association of VDR and GC gene polymorphisms with colorectal cancer risk according to plasma vitamin D concentration.

Variant Categories of plasma vitamin D Pc
Low (< 25.1 ng/mL) High (≥ 25.1 ng/mL)
Na OR (95% CI)b Na OR (95% CI)b
rs4237856 AA 105/213 1.00 (ref.) 108/210 1.00 (0.67–1.48) 0.74
CA+CC 73/140 1.04 (0.71–1.52) 70/145 0.95 (0.62–1.47)
rs4073729 GG 112/228 1.00 (ref.) 106/221 0.95 (0.64–1.40) 0.70
GA+AA 63/123 1.00 (0.67–1.47) 72/132 1.05 (0.68–1.64)
rs7970314 AA 44/93 1.00 (ref.) 48/95 0.99 (0.57–1.70) 0.93
GA+GG 133/260 1.04 (0.68–1.60) 130/259 1.00 (0.62–1.61)
rs11568820 (Cdx2) CC 67/134 1.00 (ref.) 67/136 0.92 (0.58–1.47) 0.78
TC+TT 110/219 0.96 (0.66–1.41) 111/218 0.96 (0.63–1.48)
rs7299460 TT 42/90 1.00 (ref.) 48/93 1.05 (0.61–1.82) 0.70
TC+CC 136/263 1.10 (0.71–1.68) 130/262 1.03 (0.64–1.65)
rs7136534 CC 77/158 1.00 (ref.) 77/157 0.96 (0.62–1.50) 1.00
TC+TT 101/195 1.05 (0.73–1.51) 101/198 1.01 (0.66–1.54)
rs10875695 CC 70/143 1.00 (ref.) 71/142 0.98 (0.62–1.54) 0.91
CA+AA 108/210 1.02 (0.70–1.49) 107/213 0.97 (0.64–1.49)
rs4334089 GG 64/137 1.00 (ref.) 66/136 1.00 (0.63–1.59) 0.84
GA+AA 114/216 1.11 (0.76–1.63) 112/219 1.05 (0.68–1.62)
rs4760648 CC 50/104 1.00 (ref.) 45/99 0.88 (0.51–1.53) 0.73
TC+TT 128/249 1.06 (0.71–1.58) 133/256 1.04 (0.67–1.60)
rs2853564 AA 82/175 1.00 (ref.) 70/163 0.87 (0.56–1.35) 0.47
GA+GG 96/178 1.16 (0.80–1.67) 108/192 1.23 (0.80–1.88)
rs2238136 CC 116/210 1.00 (ref.) 125/231 0.97 (0.66–1.42) 0.90
TC+TT 62/143 0.82 (0.56–1.20) 53/124 0.77 (0.49–1.20)
rs2254210 GG 88/201 1.00 (ref.) 84/185 1.01 (0.66–1.55) 0.83
GA+AA 89/152 1.36 (0.93–1.99) 94/169 1.30 (0.84–2.02)
rs2228570 (FokI) GG 66/138 1.00 (ref.) 65/135 0.95 (0.59–1.54) 0.96
GA+AA 112/215 1.09 (0.75–1.59) 113/220 1.05 (0.69–1.61)
rs2239186 AA 47/94 1.00 (ref.) 57/101 1.07 (0.63–1.84) 0.61
GA+GG 131/259 0.96 (0.64–1.46) 121/254 0.89 (0.56–1.42)
rs2189480 TT 62/153 1.00 (ref.) 58/122 1.11 (0.69–1.80) 0.38
TG+GG 116/200 1.42 (0.97–2.07) 120/233 1.23 (0.81–1.88)
rs2239179 TT 99/214 1.00 (ref.) 95/201 0.98 (0.65–1.46) 0.85
TC+CC 79/139 1.24 (0.86–1.78) 83/154 1.15 (0.76–1.75)
rs1540339 TT 84/197 1.00 (ref.) 88/185 1.05 (0.69–1.60) 0.46
TC+CC 94/156 1.44 (1.00–2.06) 90/170 1.25 (0.82–1.90)
rs2283342 GG 45/109 1.00 (ref.) 52/83 1.41 (0.82–2.44) 0.08
GA+AA 133/244 1.33 (0.88–2.01) 126/272 1.11 (0.70–1.77)
rs2107301 AA 81/188 1.00 (ref.) 84/181 1.03 (0.67–1.57) 0.62
GA+GG 97/165 1.38 (0.97–1.98) 94/174 1.25 (0.82–1.91)
rs2239182 TT 100/216 1.00 (ref.) 93/204 0.95 (0.64–1.42) 0.98
TC+CC 78/137 1.25 (0.87–1.79) 85/150 1.20 (0.79–1.81)
rs11168267 GG 127/243 1.00 (ref.) 136/239 1.08 (0.74–1.56) 0.23
GA+AA 51/110 0.88 (0.59–1.31) 42/116 0.67 (0.42–1.06)
rs10875692 CC 137/273 1.00 (ref.) 137/287 0.92 (0.64–1.31) 0.45
TC+TT 41/80 1.08 (0.70–1.66) 41/68 1.25 (0.77–2.04)
rs11574113 CC 124/228 1.00 (ref.) 134/228 1.09 (0.75–1.58) 0.24
GC+GG 54/125 0.79 (0.54–1.16) 44/127 0.61 (0.39–0.97)
rs7975232 (ApaI) CC 85/177 1.00 (ref.) 98/159 1.23 (0.81–1.87) 0.06
CA+AA 93/176 1.07 (0.74–1.53) 80/196 0.81 (0.53–1.23)
rs731236 (TaqI) AA 131/292 1.00 (ref.) 133/271 1.05 (0.74–1.50) 0.17
GA+GG 47/61 1.69 (1.10–2.60) 45/84 1.16 (0.72–1.87)
rs3847987 CC 124/233 1.00 (ref.) 134/228 1.11 (0.76–1.62) 0.16
CA+AA 54/120 0.84 (0.57–1.25) 44/127 0.63 (0.40–0.99)
rs11574143 CC 127/241 1.00 (ref.) 140/235 1.13 (0.78–1.64) 0.09
TC+TT 51/112 0.87 (0.58–1.29) 38/120 0.60 (0.37–0.95)
rs7968585 CC 87/187 1.00 (ref.) 104/165 1.28 (0.85–1.94) 0.025
TC+TT 91/166 1.14 (0.79–1.64) 74/190 0.81 (0.53–1.24)
rs12721364 AA 57/113 1.00 (ref.) 64/116 1.02 (0.62–1.67) 0.79
GA+GG 120/240 0.99 (0.67–1.47) 114/238 0.93 (0.60–1.45)
rs4588 GG 92/182 1.00 (ref.) 108/222 0.95 (0.64–1.42) 0.89
TG+TT 86/171 1.00 (0.69–1.45) 70/133 0.99 (0.63–1.55)
rs7041 AA 101/212 1.00 (ref.) 96/170 1.14 (0.75–1.72) 0.20
CA+CC 77/141 1.15 (0.79–1.67) 82/185 0.92 (0.61–1.40)

VDR SNPs are ordered by their occurrence in the gene from 5′ to 3′ end.

aNumber of cases/controls.

bOdds ratios (OR) and 95% confidence intervals (CI). Adjusted for age, sex, fasting time, and season of blood sampling (matching factors), and smoking, alcohol use, physical activity, body mass index, and family history of colorectal cancer.

cP values for interaction, unadjusted for multiple comparisons. Interaction P value after multiple comparison adjustment was 1.00 for all models except for one associated with rs7968585, which was 0.38.